Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in Elderly Patients With AML
NCT01113502Phase 2Terminated
- Sponsor
- Abramson Cancer Center
- Start
- Jun 2010
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in acute myeloid leukemia (AML), sponsored by Abramson Cancer Center. Started Jun 2010; status: terminated.
02
Drugs
eltrombopag
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01113502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113502.